Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new medical research sites and contacts, while several previous sites and contacts have been removed. Notably, the names of key personnel and locations have changed, indicating a shift in the research network.
    Difference
    3%
    Check dated 2025-06-28T00:49:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.3%
    Check dated 2025-06-20T19:35:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T16:15:33.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.16.2, replacing the previous version v2.16.1. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.
    Difference
    0.0%
    Check dated 2025-06-06T09:40:06.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in the number of study locations from 373 to 377, with several new locations added in India and Hungary, while some previous locations have been withdrawn. Additionally, the ClinicalTrials.gov data ingest modernization is scheduled for June 2025, allowing API users to provide input.
    Difference
    2%
    Check dated 2025-05-30T04:37:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new details about the Phase 3 study for psychosis associated with Alzheimer's disease, including additional locations and changes in eligibility criteria. Notably, the study now includes a new identifier and has expanded its recruitment sites.
    Difference
    63%
    Check dated 2025-05-23T01:56:08.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.